These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2033252

  • 1. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors.
    Sidell N, Taga T, Hirano T, Kishimoto T, Saxon A.
    J Immunol; 1991 Jun 01; 146(11):3809-14. PubMed ID: 2033252
    [Abstract] [Full Text] [Related]

  • 2. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS, Lee BS, Yang Y, Park CW, Ha HJ, Pyun KH, Choi I.
    Cell Immunol; 1996 Mar 15; 168(2):174-83. PubMed ID: 8640863
    [Abstract] [Full Text] [Related]

  • 3. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
    Schwabe M, Brini AT, Bosco MC, Rubboli F, Egawa M, Zhao J, Princler GL, Kung HF.
    J Clin Invest; 1994 Dec 15; 94(6):2317-25. PubMed ID: 7989587
    [Abstract] [Full Text] [Related]

  • 4. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L, Gudas LJ.
    J Cell Physiol; 2002 Nov 15; 193(2):244-52. PubMed ID: 12385002
    [Abstract] [Full Text] [Related]

  • 5. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J, Miller WH.
    Cancer Res; 1994 Dec 15; 54(24):6549-56. PubMed ID: 7987855
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
    Lasfar A, Wietzerbin J, Billard C.
    Eur J Immunol; 1994 Jan 15; 24(1):124-30. PubMed ID: 8020547
    [Abstract] [Full Text] [Related]

  • 7. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
    Taetle R, Dos Santos B, Akamatsu K, Koishihara Y, Ohsugi Y.
    Clin Cancer Res; 1996 Feb 15; 2(2):253-9. PubMed ID: 9816167
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P, Neri P, Burger R, Savino R, Shammas M, Catley L, Podar K, Chauhan D, Masciari S, Gozzini A, Tagliaferri P, Venuta S, Munshi NC, Anderson KC.
    Clin Cancer Res; 2005 Jun 01; 11(11):4251-8. PubMed ID: 15930364
    [Abstract] [Full Text] [Related]

  • 9. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
    Keller ET, Ershler WB.
    J Immunol; 1995 Apr 15; 154(8):4091-8. PubMed ID: 7706747
    [Abstract] [Full Text] [Related]

  • 10. Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells.
    Smith MR, Xie T, Joshi I, Schilder RJ.
    Br J Haematol; 1998 Sep 15; 102(4):1090-7. PubMed ID: 9734662
    [Abstract] [Full Text] [Related]

  • 11. [Interleukin 6 receptors on human bronchial epithelial cells].
    Takizawa H, Ito K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec 15; 30 Suppl():77-81. PubMed ID: 1306242
    [Abstract] [Full Text] [Related]

  • 12. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
    Okuno Y, Takahashi T, Suzuki A, Fukumoto M, Nakamura K, Fukui H, Koishihara Y, Ohsugi Y, Imura H.
    Exp Hematol; 1992 May 15; 20(4):395-400. PubMed ID: 1568457
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts.
    Zitnik RJ, Kotloff RM, Latifpour J, Zheng T, Whiting NL, Schwalb J, Elias JA.
    J Immunol; 1994 Feb 01; 152(3):1419-27. PubMed ID: 8301142
    [Abstract] [Full Text] [Related]

  • 14. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD, De Vos J, Jourdan M, Couderc G, Lu ZY, Rossi JF, Klein B.
    Oncogene; 2002 Apr 11; 21(16):2584-92. PubMed ID: 11971193
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells.
    Jiang XP, Yang DC, Elliott RL, Head JF.
    Anticancer Res; 2011 Sep 11; 31(9):2899-906. PubMed ID: 21868536
    [Abstract] [Full Text] [Related]

  • 16. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK, Weizer AK, Borsellino S, Bukowski RM, Ganapathi R, Rice T, Casey G, Kawamura K.
    Cell Growth Differ; 1996 Jul 11; 7(7):923-9. PubMed ID: 8809410
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
    Levy Y, Labaume S, Colombel M, Brouet JC.
    Clin Exp Immunol; 1996 Apr 11; 104(1):167-72. PubMed ID: 8603522
    [Abstract] [Full Text] [Related]

  • 18. Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop.
    Jernberg-Wiklund H, Pettersson M, Carlsson M, Nilsson K.
    Leukemia; 1992 Apr 11; 6(4):310-8. PubMed ID: 1588793
    [Abstract] [Full Text] [Related]

  • 19. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo.
    Suzuki H, Yasukawa K, Saito T, Goitsuka R, Hasegawa A, Ohsugi Y, Taga T, Kishimoto T.
    Eur J Immunol; 1992 Aug 11; 22(8):1989-93. PubMed ID: 1639101
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M.
    Silvani A, Ferrari G, Paonessa G, Toniatti C, Parmiani G, Colombo MP.
    Cancer Res; 1995 May 15; 55(10):2200-5. PubMed ID: 7743524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.